Cargando…

Quetiapine fumarate augmentation for patients with a primary anxiety disorder or a mood disorder: a pilot study

BACKGROUND: Comorbid anxiety symptoms,in patients with a primary anxiety disorder or a mood disorder, leads to poor patient outcomes and burdens the healthcare system. This pilot study evaluated the feasibility of extended-release quetiapine fumarate (quetiapine XR) for the treatment of patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yi-Chih, Chen, Chih-Ken, Wang, Liang-Jen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514148/ https://www.ncbi.nlm.nih.gov/pubmed/23020711 http://dx.doi.org/10.1186/1471-244X-12-162

Ejemplares similares

Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders
por: El-Khalili, Nizar
Publicado: (2012)

Effects of once-daily extended release quetiapine fumarate on patient-reported outcomes in patients with generalized anxiety disorder
por: Endicott, Jean, et al.
Publicado: (2012)

A randomized, double-blind study of the efficacy and tolerability of extended-release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder
por: Wang, Gang, et al.
Publicado: (2014)

Quetiapine N-oxide–fumaric acid (2/1)
por: Shen, Jin, et al.
Publicado: (2012)

The management of schizophrenia: focus on extended-release quetiapine fumarate
por: Peuskens, Joseph
Publicado: (2011)

Branch retinal vein occlusion associated with quetiapine fumarate
por: Yong, Ku Chui, et al.
Publicado: (2011)

Anxiety and mood disorder in young males with mitral valve prolapse
por: Lung, For-Wey, et al.
Publicado: (2008)

New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine
por: Baune, Bernhard T
Publicado: (2008)

Active Metabolites as Antidepressant Drugs: The Role of Norquetiapine in the Mechanism of Action of Quetiapine in the Treatment of Mood Disorders
por: López-Muñoz, Francisco, et al.
Publicado: (2013)

Formulation Design and Optimization of Orodispersible Tablets of Quetiapine Fumarate by Sublimation Method
por: Kalyankar, P., et al.
Publicado: (2015)

Quetiapine in the treatment of schizophrenia and related disorders
por: Riedel, Michael, et al.
Publicado: (2007)

Differentiation of autism spectrum disorder and mood or anxiety disorder
por: Wittkopf, Sarah, et al.
Publicado: (2021)

Childhood trauma and treatment outcomes during mood‐stabilising treatment with lithium or quetiapine among outpatients with bipolar disorder
por: Wrobel, Anna L., et al.
Publicado: (2022)

Signs of Mood and Anxiety Disorders in Chimpanzees
por: Ferdowsian, Hope R., et al.
Publicado: (2011)

Welcome to Biology of Mood & Anxiety Disorders
por: Hariri, Ahmad R, et al.
Publicado: (2011)

Translational Neuroimaging of the Mood and Anxiety Disorders
por: Lui, Su, et al.
Publicado: (2014)

Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors
por: Bedse, Gaurav, et al.
Publicado: (2018)

Quality by Design Approach for Development and Characterisation of  Solid Lipid Nanoparticles of Quetiapine Fumarate
por: Agarwal, Shweta, et al.
Publicado: (2020)

Effects of mood episodes and comorbid anxiety on neuropsychological impairment in patients with bipolar spectrum disorder
por: Huang, Chih‐Chun, et al.
Publicado: (2020)

The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder
por: Bartova, Lucie, et al.
Publicado: (2021)

Olanzapine and quetiapine in the prevention of a new mood episode in women with bipolar disorder during the postpartum period: a retrospective cohort study
por: Uguz, Faruk, et al.
Publicado: (2021)

Quetiapine-induced behavioral disorder during sleep
por: Uvais, N. A., et al.
Publicado: (2019)

Pharmacokinetic evaluation of quetiapine fumarate controlled release hybrid hydrogel: a healthier treatment of schizophrenia
por: Akhlaq, Muhammad, et al.
Publicado: (2018)

Pilot Testing a Brief Partner-Inclusive Hybrid Intervention for Perinatal Mood and Anxiety Disorders
por: Peifer, Janelle S., et al.
Publicado: (2022)

Early Life Stress, Mood, and Anxiety Disorders
por: Syed, Shariful A., et al.
Publicado: (2017)

Editorial: Neuroimaging Biomarkers in Mood and Anxiety Disorders
por: Lai, Chien-Han, et al.
Publicado: (2021)

Interaction of Heavy Drinking Patterns and Depression Severity Predicts Efficacy of Quetiapine Fumarate XR in Lowering Alcohol Intake in Alcohol Use Disorder Patients
por: Vatsalya, Vatsalya, et al.
Publicado: (2020)

Preparation, Characterization and Evaluation of Quetiapine Fumarate Solid Lipid Nanoparticles to Improve the Oral Bioavailability
por: Narala, Arjun, et al.
Publicado: (2013)

Central Composite Optimization of Glycerosomes for the Enhanced Oral Bioavailability and Brain Delivery of Quetiapine Fumarate
por: Zaki, Randa Mohammed, et al.
Publicado: (2022)

Results from a drug utilization study of extended release quetiapine fumarate prescribed by psychiatrists as treatment for major depressive disorder in selected countries in the European Union
por: Brody, Robert S., et al.
Publicado: (2018)

A Semantic Cognition Contribution to Mood and Anxiety Disorder Pathophysiology
por: González-García, Iván, et al.
Publicado: (2023)

Role of extended release quetiapine in the management of bipolar disorders
por: Al Jurdi, Rayan K, et al.
Publicado: (2010)

Effect of Polymers and Permeation Enhancers in the Release of Quetiapine Fumarate Transdermal Patch through the Dialysis Membrane
por: Bhupathyraaj, Mullaicharam, et al.
Publicado: (2022)

The Influence of Prenatal Exposure to Quetiapine Fumarate on the Development of Dopaminergic Neurons in the Ventral Midbrain of Mouse Embryos
por: Alsanie, Walaa F., et al.
Publicado: (2022)

The genetic basis of mood and anxiety disorders – changing paradigms
por: Binder, Elisabeth B
Publicado: (2012)

Imaging the Role of Inflammation in Mood and Anxiety-related Disorders
por: Felger, Jennifer C.
Publicado: (2018)

Coma After Quetiapine Fumarate Intentional Overdose in a 71-year-old Man: A Case Report
por: Gibiino, S., et al.
Publicado: (2015)

Convulsive syncope related to a small dose of quetiapine in an adolescent with bipolar disorder
por: Lai, Jianbo, et al.
Publicado: (2017)

Memantine as an Augmentation Therapy for Anxiety Disorders
por: Schwartz, Thomas L., et al.
Publicado: (2012)

Disability in patients consulting for anxiety or mood disorders in primary care: response to antidepressant treatment
por: Gérard, Alain, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4nmtui2gob59lmgfnp8p4vr3cr